A team of scientists from Australia is making progress in developing a vaccine that protects the human “surfaces” most likely to encounter the virus first.

To get its dengue vaccine candidate into a 20,000-patient Phase III study, Takeda's vax unit had to stoke up a global growth spurt.

It’s another silver lining for drugmakers targeting HIV: Researchers have found promise in a combo of a Johnson & Johnson vaccine and a Gilead immune…

In a move that illustrates the stepped-up pace of Zika vaccine development, the Walter Reed Army Institute of Research is moving into human testing for its…

Many people don't get the vaccines recommended by public health experts--and it's taking a toll on the U.S. economy. In fact, unvaccinated adults…

International charity Médecins Sans Frontières has urged Pfizer for years to cut the prices on its pneumococcal vaccines. After all, Prevnar and Prevnar 13…

After tying the knot with Sanofi on testing a Zika vaccine candidate, the Walter Reed Army Institute of Research has enlisted Engility for a $10 million…

Chasing two U.S.-developed vaccine candidates, India’s Bharat Biotech says it’s ready to start testing its Zika shot in humans. It just needs the go-ahead from…

On the heels of crushing Phase III results for its pancreatic cancer candidate, NewLink Genetics has won a lifeline from the U.S. government. The biotech…

Infectious Diseases